Cervical Cancer Diagnostic Tests Market (Diagnostic Test: Pap Smear Test, HPV Test, Colposcopy, Biopsy & Endocervical Curettage, and Other Diagnostic Tests) - Global-Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

PUBLISHED: June 16, 2022

PAGES: 160 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

The report provides revenue of the global cervical cancer diagnostic tests market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cervical cancer diagnostic tests market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cervical cancer diagnostic tests market.

The report delves into the competitive landscape of the global cervical cancer diagnostic tests market. Key players operating in the global cervical cancer diagnostic tests market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cervical cancer diagnostic tests market profiled in this report.

Product Code: TMRGL736

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cervical Cancer Diagnostic Tests Market

4. Market Overview

4.1. Introduction
- 4.1.1. Diagnostic Test Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Cervical Cancer Diagnostic Tests Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Cervical Cancer Diagnostic Tests Market Analysis and Forecast, by Diagnostic Test

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Diagnostic Test, 2017-2031
- 6.3.1. Pap Smear Test
- 6.3.2. HPV Test
- 6.3.3. Colposcopy
- 6.3.4. Biopsy & Endocervical Curettage
- 6.3.5. Other diagnostic tests
6.4. Market Attractiveness Analysis, by Diagnostic Test

7. Global Cervical Cancer Diagnostic Tests Market Analysis and Forecast, by End-user

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2031
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics
- 7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user

8. Global Cervical Cancer Diagnostic Tests Market Analysis and Forecast, by Region

8.1. Key Findings
8.2. Market Value Forecast, by Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region

9. North America Cervical Cancer Diagnostic Tests Market Analysis and Forecast

9.1. Introduction
- 9.1.1. Key Findings
9.2. Market Value Forecast, by Diagnostic Test, 2017-2031
- 9.2.1. Pap Smear Test
- 9.2.2. HPV Test
- 9.2.3. Colposcopy
- 9.2.4. Biopsy & Endocervical Curettage
- 9.2.5. Other diagnostic tests
9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospitals
- 9.3.2. Specialty Clinics
- 9.3.3. Others
9.4. Market Value Forecast, by Country, 2017-2031
- 9.4.1. U.S.
- 9.4.2. Canada
9.5. Market Attractiveness Analysis
- 9.5.1. By Diagnostic Test
- 9.5.2. By End-user
- 9.5.3. By Country

10. Europe Cervical Cancer Diagnostic Tests Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. Market Value Forecast, by Diagnostic Test, 2017-2031
- 10.2.1. Pap Smear Test
- 10.2.2. HPV Test
- 10.2.3. Colposcopy
- 10.2.4. Biopsy & Endocervical Curettage
- 10.2.5. Other diagnostic tests
10.3. Market Value Forecast, by End-user, 2017-2031
- 10.3.1. Hospitals
- 10.3.2. Specialty Clinics
- 10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Spain
- 10.4.5. Italy
- 10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
- 10.5.1. By Diagnostic Test
- 10.5.2. By End-user
- 10.5.3. By Country Country/Sub-region

11. Asia Pacific Cervical Cancer Diagnostic Tests Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Diagnostic Test, 2017-2031
- 11.2.1. Pap Smear Test
- 11.2.2. HPV Test
- 11.2.3. Colposcopy
- 11.2.4. Biopsy & Endocervical Curettage
- 11.2.5. Other diagnostic tests
11.3. Market Value Forecast, by End-user, 2017-2031
- 11.3.1. Hospitals
- 11.3.2. Specialty Clinics
- 11.3.3. Others
11.4. Market Value Forecast, by Country Country/Sub-region, 2017-2031
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
- 11.5.1. By Diagnostic Test
- 11.5.2. By End-user
- 11.5.3. By Country Country/Sub-region

12. Latin America Cervical Cancer Diagnostic Tests Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Diagnostic Test, 2017-2031
- 12.2.1. Pap Smear Test
- 12.2.2. HPV Test
- 12.2.3. Colposcopy
- 12.2.4. Biopsy & Endocervical Curettage
- 12.2.5. Other diagnostic tests
12.3. Market Value Forecast, by End-user, 2017-2031
- 12.3.1. Hospitals
- 12.3.2. Specialty Clinics
- 12.3.3. Others
12.4. Market Value Forecast, by Country Country/Sub-region, 2017-2031
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
- 12.5.1. By Diagnostic Test
- 12.5.2. By End-user
- 12.5.3. By Country Country/Sub-region

13. Middle East & Africa Cervical Cancer Diagnostic Tests Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Diagnostic Test, 2017-2031
- 13.2.1. Pap Smear Test
- 13.2.2. HPV Test
- 13.2.3. Colposcopy
- 13.2.4. Biopsy & Endocervical Curettage
- 13.2.5. Other diagnostic tests
13.3. Market Value Forecast, by End-user, 2017-2031
- 13.3.1. Hospitals
- 13.3.2. Specialty Clinics
- 13.3.3. Others
13.4. Market Value Forecast, by Country Country/Sub-region, 2017-2031
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
- 13.5.1. By Diagnostic Test
- 13.5.2. By End-user
- 13.5.3. By Country Country/Sub-region

14. Competition Landscape

14.1. Market Player - Competition Matrix
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
- 14.3.1. Abbott
  - 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 14.3.1.2. Product Portfolio
  - 14.3.1.3. SWOT Analysis
  - 14.3.1.4. Strategic Overview
- 14.3.2. BD
  - 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 14.3.2.2. Product Portfolio
  - 14.3.2.3. SWOT Analysis
  - 14.3.2.4. Strategic Overview
- 14.3.3. Cooper Companies, Inc.
  - 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 14.3.3.2. Product Portfolio
  - 14.3.3.3. SWOT Analysis
  - 14.3.3.4. Strategic Overview
- 14.3.4. DYSIS Medical, Inc.
  - 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 14.3.4.2. Product Portfolio
  - 14.3.4.3. SWOT Analysis
  - 14.3.4.4. Strategic Overview
- 14.3.5. F. Hoffmann-La Roche Ltd.
  - 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 14.3.5.2. Product Portfolio
  - 14.3.5.3. SWOT Analysis
  - 14.3.5.4. Strategic Overview
- 14.3.6. Femasys, Inc.
  - 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 14.3.6.2. Product Portfolio
  - 14.3.6.3. SWOT Analysis
  - 14.3.6.4. Strategic Overview
- 14.3.7. Guided Therapeutics, Inc.
  - 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 14.3.7.2. Product Portfolio
  - 14.3.7.3. SWOT Analysis
  - 14.3.7.4. Strategic Overview
- 14.3.8. Hologic, Inc.
  - 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 14.3.8.2. Product Portfolio
  - 14.3.8.3. SWOT Analysis
  - 14.3.8.4. Strategic Overview
- 14.3.9. QIAGEN
  - 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 14.3.9.2. Product Portfolio
  - 14.3.9.3. SWOT Analysis
  - 14.3.9.4. Strategic Overview
- 14.3.10. Quest Diagnostics Incorporated
  - 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 14.3.10.2. Product Portfolio
  - 14.3.10.3. SWOT Analysis
  - 14.3.10.4. Strategic Overview

Product Code: TMRGL736

List of Table

Table 01: Global Cervical Cancer Diagnostic Tests Market Value (US$ Mn) Forecast, by Product, 2022-2031
Table 02: Global Cervical Cancer Diagnostic Tests Market Value (US$ Mn) Forecast, by End-user, 2022-2031
Table 03: Global Cervical Cancer Diagnostic Tests Market Value (US$ Mn) Forecast, by Region, 2022-2031
Table 04: North America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Country, 2022-2031
Table 05: North America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Product, 2022-2031
Table 06: North America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by End-user, 2022-2031
Table 07: Europe Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
Table 08: Europe Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Product, 2022-2031
Table 09: Europe Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by End-user, 2022-2031
Table 10: Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
Table 11: Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Product, 2022-2031
Table 12: Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by End-user, 2022-2031
Table 13: Latin America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
Table 14: Latin America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Product, 2022-2031
Table 15: Latin America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by End-user, 2022-2031
Table 16: Middle East & Africa Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
Table 17: Middle East & Africa Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Product, 2022-2031
Table 18: Middle East & Africa Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by End-user, 2022-2031

List of Figures

Figure 01: Global Cervical Cancer Diagnostic Tests Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Cervical Cancer Diagnostic Tests Market Value Share Analysis, by Diagnostic Test, 2021 and 2031
Figure 03: Global Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pap Smear Test, 2017-2031
Figure 04 Global Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by HPV Test, 2017-2031
Figure 05: Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colposcopy, 2017-2031
Figure 06: Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biopsy & Endocervical Curettage, 2017-2031
Figure 07: Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
Figure 08: Global Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2022-2031
Figure 09: Global Cervical Cancer Diagnostic Tests Market Value Share Analysis, by End-user, 2021 and 2031
Figure 10: Global Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2031
Figure 11: Global Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017-2031
Figure 12: Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
Figure 13: Global Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2022-2031
Figure 14: Global Cervical Cancer Diagnostic Tests Market Scenario, 2022-2031
Figure 15: Global Cervical Cancer Diagnostic Tests Market Value Share Analysis, by Region, 2022 and 2031
Figure 16: Global Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Region, 2022-2031
Figure 17: North America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 18: North America Cervical Cancer Diagnostic Tests Market Value Share (%), by Country, 2021 and 2031
Figure 19: North America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Country, 2022-2031
Figure 20: North America Cervical Cancer Diagnostic Tests Market Value Share (%), by Product, 2021 and 2031
Figure 21: North America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2022-2031
Figure 22: North America Cervical Cancer Diagnostic Tests Market Value Share (%), by End-user, 2021 and 2031
Figure 23: North America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2022-2031
Figure 24: Europe Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 25: Europe Cervical Cancer Diagnostic Tests Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 26: Europe Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 27: Europe Cervical Cancer Diagnostic Tests Market Value Share (%), by Product, 2021 and 2031
Figure 28: Europe Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2022-2031
Figure 29: Europe Cervical Cancer Diagnostic Tests Market Value Share (%), by End-user, 2021 and 2031
Figure 30: Europe Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2021-2031
Figure 31: Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022-2031
Figure 32: Asia Pacific Cervical Cancer Diagnostic Tests Market Value Share (%), by Country/Sub-region, 2017 and 2031
Figure 33: Asia Pacific Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 34: Asia Pacific Cervical Cancer Diagnostic Tests Market Value Share (%), by Product, 2021 and 2031
Figure 35: Asia Pacific Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2021-2031
Figure 36: Asia Pacific Cervical Cancer Diagnostic Tests Market Value Share (%), by End-user, 2021 and 2031
Figure 37: Asia Pacific Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2022-2031
Figure 38: Latin America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022-2031
Figure 39: Latin America Cervical Cancer Diagnostic Tests Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 40: Latin America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 41: Latin America Cervical Cancer Diagnostic Tests Market Value Share (%), by Product, 2021 and 2031
Figure 42: Latin America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2022-2031
Figure 43: Latin America Cervical Cancer Diagnostic Tests Market Value Share (%), by End-user, 2022 and 2031
Figure 44: Latin America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2022-2031
Figure 45: Middle East & Africa Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022-2031
Figure 46: Middle East & Africa Cervical Cancer Diagnostic Tests Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 47: Middle East & Africa Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Country/Sub-region
Figure 48: Middle East & Africa Cervical Cancer Diagnostic Tests Market Value Share (%), by Product, 2021 and 2031
Figure 49: Middle East & Africa Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2022-2031
Figure 50: Middle East & Africa Cervical Cancer Diagnostic Tests Market Value Share (%), by End-user, 2021 and 2031
Figure 51: Middle East & Africa Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2022-2031
Figure 52: Global Cervical Cancer Diagnostic Tests Market Share Analysis by Company (2021) region, 2022-2031